BriaCell Therapeutics Q3 EPS $(0.99) Up From $(16.40) YoY

Benzinga Newsdesk www.benzinga.com Negative 52.0%

Neg 52% Neu 0% Pos 0%

BriaCell Therapeutics (NASDAQ:BCTX) reported quarterly losses of $(0.99) per share. This is a 93.96 percent increase over losses of $(16.40) per share from the same period last year.